Yenerall P, Kollipara R, Avila K, Peyton M, Eide C, Bottomly D, et al. Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations. Cancer Res. 2021;81:4685-4695 pubmed 出版商

Glorieux C, Xia X, He Y, Hu Y, Cremer K, Robert A, et al. Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling. Redox Biol. 2021;38:101780 pubmed 出版商

Aikin T, Peterson A, Pokrass M, Clark H, Regot S. MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression. elife. 2020;9: pubmed 出版商

Sachs N, Papaspyropoulos A, Zomer van Ommen D, Heo I, Böttinger L, Klay D, et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 2019;38: pubmed 出版商

Han F, Li C, Cai Z, Zhang X, Jin G, Zhang W, et al. The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance. Nat Commun. 2018;9:4728 pubmed 出版商

Sechet E, Telford E, Bonamy C, Sansonetti P, Sperandio B. Natural molecules induce and synergize to boost expression of the human antimicrobial peptide β-defensin-3. Proc Natl Acad Sci U S A. 2018;115:E9869-E9878 pubmed 出版商

Tavolari S, Munarini A, Storci G, Laufer S, Chieco P, Guarnieri T. The decrease of cell membrane fluidity by the non-steroidal anti-inflammatory drug Licofelone inhibits epidermal growth factor receptor signalling and triggers apoptosis in HCA-7 colon cancer cells. Cancer Lett. 2012;321:187-94 pubmed 出版商

Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 2012;483:100-3 pubmed 出版商

Kitajima S, Miki T, Takegami Y, Kido Y, Noda M, Hara E, et al. Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling. Oncogene. 2011;30:737-50 pubmed 出版商